The effectiveness of oral contraception is unaffected by weight or body mass index (BMI), and failure rates decline with age and duration of use, according to a study of European users.
The effectiveness of oral contraception is unaffected by weight or body mass index (BMI), and failure rates decline with age and duration of use, according to a study of European users published in the September issue of the American Journal of Obstetrics and Gynecology.
Jürgen C. Dinger, MD, of the ZEG-Center for Epidemiology and Health Research in Berlin, and colleagues analyzed data from the European Active Surveillance Study on Oral Contraceptives on 59,510 users of oral contraception. The researchers looked at how effective the contraceptive method was overall and by a range of factors, including subjects' BMI, weight, age, dose, type of regimen, duration of use, and parity. They also confirmed by interview the 545 self-reported unplanned pregnancies.
The data covered 112,659 women-years of exposure to oral contraceptives (OCs) and revealed that weight and BMI had little impact on effectiveness, the investigators note. Women over the age of 30 years had lower rates of contraceptive failure, and increased duration of use was also associated with a drop in OC failure.
The study was funded by Bayer Schering Pharma AG.
Dinger JC, Cronin M, Möhner S, et al. Oral contraceptive effectiveness according to body mass index, weight, age, and other factors. Am J Obstet Gynecol. 2001: 263.e1-263.e9.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More